Skip to main content

Table 3 Performance of disease detection for PET/MR vs PET/CT at staging, interim and end of treatment assessments

From: Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma

Staging

 Sensitivity

96% (95% CI, 94% to 98%)

 Specificity

100.00% (95% CI, 99% to 100%)

 Kappa

0.976 (p < 0.001)

Interim

 Sensitivity

70% (95% CI, 50% to 86%)

 Specificity

100% (95% CI, 99% to 100%)

 Kappa

0.819 (p < 0.001)

End of treatment

 Sensitivity

100% (95% CI, 75% to 100%)

 Specificity

100% (95% CI, 99% to 100%)

 Kappa

1.0 (p < 0.001)

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us